Effective Biomarkers for advance fibrosis NASH and reflect biomarkers as changes of liver fibrosis with NASH

被引：0
|
作者：
Kawanaka, Miwa [1 ]
Nishino, Ken [1 ]
Tanikawa, Tomohiro [1 ]
Oka, Takahito [1 ]
Urata, Noriyo [1 ]
Nakamura, Jun [1 ]
Suehiro, Mitsuhiko [1 ]
Sasai, Takako [1 ]
Kawamoto, Hirofumi [1 ]
机构：
[1] Kawasaki Med Sch, Gen Internal Med 2, Gen Med Ctr, Okayama, Japan
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2113
引用
收藏
页码：1115A / 1115A
页数：1
相关论文
共 50 条
  • [1] Imaging biomarkers of NAFLD, NASH, and fibrosis
    Ajmera, Veeral
    Loomba, Rohit
    [J]. MOLECULAR METABOLISM, 2020, 50
  • [2] Diagnostic performance of biomarkers for NASH and fibrosis
    不详
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (11): : 972 - 972
  • [3] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Z. Wang
    Z. Zhao
    Y. Xia
    Z. Cai
    C. Wang
    Y. Shen
    R. Liu
    H. Qin
    J. Jia
    G. Yuan
    [J]. Journal of Endocrinological Investigation, 2022, 45 : 1379 - 1392
  • [4] Editorial: Noninvasive Fibrosis Biomarkers in Patients With NASH With Diabetes
    Fan, Weiguo
    Torok, Natalie J.
    [J]. HEPATOLOGY COMMUNICATIONS, 2021, 5 (04) : 553 - 555
  • [5] Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
    Wang, Z.
    Zhao, Z.
    Xia, Y.
    Cai, Z.
    Wang, C.
    Shen, Y.
    Liu, R.
    Qin, H.
    Jia, J.
    Yuan, G.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (07) : 1379 - 1392
  • [6] SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH
    Luo, Yi
    Wadhawan, Samir
    Greenfield, Alex
    Decato, Benjamin E.
    Oseini, Abdul M.
    Collen, Rebecca
    Shevell, Diane E.
    Thompson, John
    Jarai, Gabor
    Charles, Edgar D.
    Sanyal, Arun J.
    [J]. HEPATOLOGY COMMUNICATIONS, 2021, 5 (05) : 760 - 773
  • [7] CAN BIOMARKERS OF FIBROSIS (FIBROTEST), STEATOSIS (STEATOTEST) AND NASH (NASHTEST) BE RELIABLE SURROGATES FOR LIVER BIOPSY IN NASH THERAPEUTIC TRIALS
    Poynard, Thierry
    Munteanu, Mona
    Charlotte, Frederic
    Bernhardt, Carole
    Ratziu, Vlad
    Moussalli, Joseph
    [J]. HEPATOLOGY, 2010, 52 (04) : 640A - 641A
  • [8] Collagen formation and degradation biomarkers identify advanced fibrosis in NASH patients
    Luo, Y.
    Charles, E. D.
    Vincent, R.
    Gagnon, R.
    Oseini, A.
    Banini, B.
    Mirshahi, F.
    Daita, K.
    Christian, R.
    Sanyal, A.
    [J]. JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S676 - S677
  • [9] Composite biomarkers selected by machine learning predict severe fibrosis in NASH
    Brown, Elizabeth
    Thompson, John
    Ebert, Christina
    Apfel, Abraham
    Koenitzer, Jennifer
    Spires, Thomas
    Cvijic, Mary Ellen
    Charles, Edgar
    Luo, Yi
    Zhao, Lei
    Gordon, David
    Chung, Raymond
    Corey, Kathleen
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S417 - S417
  • [10] Diagnostic Accuracy of Fibrosis Stage of Nash in Combination with Biomarkers and Transient Elastography
    Shima, Toshihide
    Nishiwaki, Masatake
    Oya, Hirohisa
    Katayama, Takayuki
    Mitsumoto, Yasuhide
    Sakai, Kyoko
    Mizuno, Masayuki
    Kanbara, Yoshihiro
    Okanoue, Takeshi
    [J]. HEPATOLOGY, 2018, 68 : 1292A - 1293A
12345